HOWL - Werewolf Therapeutics Inc
IEX Last Trade
2.14
-0.080 -3.738%
Share volume: 150,977
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.22
-0.08
-3.60%
Fundamental analysis
12%
Profitability
8%
Dept financing
9%
Liquidity
75%
Performance
1%
Performance
5 Days
-9.62%
1 Month
-11.84%
3 Months
-59.70%
6 Months
-66.04%
1 Year
-21.74%
2 Year
-61.70%
Key data
Stock price
$2.14
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.57 - $8.19
52 WEEK CHANGE
-$0.17
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
Company detail
CEO:
Region: US
Website: werewolftx.com
Employees: 44
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: werewolftx.com
Employees: 44
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
we are an immuno-oncology company advancing a pipeline of next generation, transformative cancer treatments.
Recent news